News Regeneron’s COVID-19 drug cuts risk of death for hospitalized patients, study shows By - June 16, 2021 0 176 Facebook Twitter Pinterest WhatsApp The antibody cocktail treatment also reduced hospitalized COVID-19 patients’ chances of needing a mechanical ventilator, the lead researcher said.